Warning letter
Americaloe, Inc.: warning letter of Apr 3, 2002
FDA warning letter UCM144840 · Los Angeles District Office
Key facts
| Reference number | UCM144840 |
|---|---|
| Company | Americaloe, Inc. |
| Subject | Seasilver/New Drug/Labeling/Misbranded |
| Issue date | Apr 3, 2002 |
| Posted date | Apr 3, 2002 |
| Issuing office | Los Angeles District Office |
| Product type | Drugs |
| CFR sections cited | 3, 10, 101, 101.14, 101.36, 330 |
| Country | 3 |
| Letter on fda.gov | web.archive.org |
At a glance
- 1–9 CFR sections cited
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: